AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 178 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $435,000 | +39.0% | 31,834 | -10.7% | 0.00% | +50.0% |
Q2 2020 | $313,000 | +18.1% | 35,666 | +8.1% | 0.00% | 0.0% |
Q1 2020 | $265,000 | -8.3% | 32,982 | +3.5% | 0.00% | 0.0% |
Q4 2019 | $289,000 | -16.2% | 31,856 | -0.4% | 0.00% | -33.3% |
Q3 2019 | $345,000 | +24.1% | 31,990 | -0.3% | 0.00% | +50.0% |
Q2 2019 | $278,000 | -37.1% | 32,082 | -6.3% | 0.00% | -50.0% |
Q1 2019 | $442,000 | -12.8% | 34,222 | +2.5% | 0.00% | 0.0% |
Q4 2018 | $507,000 | -32.8% | 33,376 | -0.6% | 0.00% | -33.3% |
Q3 2018 | $755,000 | -5.4% | 33,580 | -7.2% | 0.01% | 0.0% |
Q2 2018 | $798,000 | +10.8% | 36,203 | -0.1% | 0.01% | +20.0% |
Q1 2018 | $720,000 | +38.5% | 36,254 | 0.0% | 0.01% | +66.7% |
Q4 2017 | $520,000 | -11.3% | 36,254 | -2.3% | 0.00% | -25.0% |
Q3 2017 | $586,000 | -19.5% | 37,107 | +1.2% | 0.00% | -20.0% |
Q2 2017 | $728,000 | -22.2% | 36,655 | -3.7% | 0.01% | -28.6% |
Q1 2017 | $936,000 | +11.8% | 38,047 | +4.5% | 0.01% | 0.0% |
Q4 2016 | $837,000 | -0.9% | 36,399 | +5.1% | 0.01% | 0.0% |
Q3 2016 | $845,000 | -4.5% | 34,635 | -0.2% | 0.01% | -12.5% |
Q2 2016 | $885,000 | -1.8% | 34,700 | -2.0% | 0.01% | 0.0% |
Q1 2016 | $901,000 | – | 35,404 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |